Literature DB >> 23271773

Improving the communication of benefits and harms of treatment strategies: decision AIDS for localized prostate cancer treatment decisions.

Richard M Hoffman1.   

Abstract

Treatment decisions for localized prostate cancer are preference sensitive. The optimal treatment strategy is unknown, and active treatment is not always necessary. Choosing among the various options involves tradeoffs between cancer control and complications that affect quality of life. A shared decision-making process, particularly facilitated by a decision aid, can help a patient make an informed decision that is concordant with his values and preferences. Studies have shown that informed patients are more willing to forego aggressive treatment, but much work is needed to develop and evaluate high-quality decision aids that accurately portray active surveillance. The research agenda for decision aids includes evaluating content elements and format, timing and setting for delivery, the quality of the decision-making process, and the effects of decision support on treatment selection (which will occur repeatedly for men opting for active surveillance) and quality of life.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23271773      PMCID: PMC3540882          DOI: 10.1093/jncimonographs/lgs023

Source DB:  PubMed          Journal:  J Natl Cancer Inst Monogr        ISSN: 1052-6773


  38 in total

1.  Radiotherapy and short-term androgen deprivation for localized prostate cancer.

Authors:  Christopher U Jones; Daniel Hunt; David G McGowan; Mahul B Amin; Michael P Chetner; Deborah W Bruner; Mark H Leibenhaut; Siraj M Husain; Marvin Rotman; Luis Souhami; Howard M Sandler; William U Shipley
Journal:  N Engl J Med       Date:  2011-07-14       Impact factor: 91.245

2.  Radical prostatectomy versus observation for localized prostate cancer.

Authors:  Timothy J Wilt; Michael K Brawer; Karen M Jones; Michael J Barry; William J Aronson; Steven Fox; Jeffrey R Gingrich; John T Wei; Patricia Gilhooly; B Mayer Grob; Imad Nsouli; Padmini Iyer; Ruben Cartagena; Glenn Snider; Claus Roehrborn; Roohollah Sharifi; William Blank; Parikshit Pandya; Gerald L Andriole; Daniel Culkin; Thomas Wheeler
Journal:  N Engl J Med       Date:  2012-07-19       Impact factor: 91.245

Review 3.  Health decision aids to facilitate shared decision making in office practice.

Authors:  Michael J Barry
Journal:  Ann Intern Med       Date:  2002-01-15       Impact factor: 25.391

Review 4.  Decision aids for people facing health treatment or screening decisions.

Authors:  Dawn Stacey; Carol L Bennett; Michael J Barry; Nananda F Col; Karen B Eden; Margaret Holmes-Rovner; Hilary Llewellyn-Thomas; Anne Lyddiatt; France Légaré; Richard Thomson
Journal:  Cochrane Database Syst Rev       Date:  2011-10-05

5.  Radical prostatectomy versus watchful waiting in early prostate cancer.

Authors:  Anna Bill-Axelson; Lars Holmberg; Mirja Ruutu; Hans Garmo; Jennifer R Stark; Christer Busch; Stig Nordling; Michael Häggman; Swen-Olof Andersson; Stefan Bratell; Anders Spångberg; Juni Palmgren; Gunnar Steineck; Hans-Olov Adami; Jan-Erik Johansson
Journal:  N Engl J Med       Date:  2011-05-05       Impact factor: 91.245

6.  Treatment decisions for localized prostate cancer: asking men what's important.

Authors:  E S Holmboe; J Concato
Journal:  J Gen Intern Med       Date:  2000-10       Impact factor: 5.128

7.  Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer.

Authors:  F J Fowler; M McNaughton Collins; P C Albertsen; A Zietman; D B Elliott; M J Barry
Journal:  JAMA       Date:  2000-06-28       Impact factor: 56.272

8.  Overtreatment of men with low-risk prostate cancer and significant comorbidity.

Authors:  Timothy J Daskivich; Karim Chamie; Lorna Kwan; Jessica Labo; Roland Palvolgyi; Atreya Dash; Sheldon Greenfield; Mark S Litwin
Journal:  Cancer       Date:  2010-11-29       Impact factor: 6.860

9.  Patient satisfaction with treatment decisions for clinically localized prostate carcinoma. Results from the Prostate Cancer Outcomes Study.

Authors:  Richard M Hoffman; William C Hunt; Frank D Gilliland; Robert A Stephenson; Arnold L Potosky
Journal:  Cancer       Date:  2003-04-01       Impact factor: 6.860

Review 10.  Decision aids for people facing health treatment or screening decisions.

Authors:  A M O'Connor; D Stacey; V Entwistle; H Llewellyn-Thomas; D Rovner; M Holmes-Rovner; V Tait; J Tetroe; V Fiset; M Barry; J Jones
Journal:  Cochrane Database Syst Rev       Date:  2003
View more
  9 in total

1.  Decision-making processes among men with low-risk prostate cancer: A survey study.

Authors:  Richard M Hoffman; Stephen K Van Den Eeden; Kimberly M Davis; Tania Lobo; George Luta; Jun Shan; David Aaronson; David F Penson; Amethyst D Leimpeter; Kathryn L Taylor
Journal:  Psychooncology       Date:  2017-07-13       Impact factor: 3.894

2.  Treatment decisions for localized prostate cancer: a concept mapping approach.

Authors:  Stephanie L McFall; Patricia D Mullen; Theresa L Byrd; Scott B Cantor; Yen-Chi Le; Isabel Torres-Vigil; Curtis Pettaway; Robert J Volk
Journal:  Health Expect       Date:  2014-02-09       Impact factor: 3.377

3.  Physicians' perspectives on the informational needs of low-risk prostate cancer patients.

Authors:  Charlotte J Hagerman; Paula G Bellini; Kim M Davis; Richard M Hoffman; David S Aaronson; Daniel Y Leigh; Riley E Zinar; David Penson; Stephen Van Den Eeden; Kathryn L Taylor
Journal:  Health Educ Res       Date:  2017-04-01

4.  Informed decision-making based on a leaflet in the context of prostate cancer screening.

Authors:  Tessa Dierks; Eveline A M Heijnsdijk; Ida J Korfage; Monique J Roobol; Harry J de Koning
Journal:  Patient Educ Couns       Date:  2019-04-13

5.  Perceptions of Urologists About the Conversational Elements Leading to Treatment Decision-Making Among Newly Diagnosed Prostate Cancer Patients.

Authors:  Prajakta Adsul; Ricardo Wray; Danielle Boyd; Nancy Weaver; Sameer Siddiqui
Journal:  J Cancer Educ       Date:  2017-09       Impact factor: 2.037

6.  Patient-physician communication about early stage prostate cancer: analysis of overall visit structure.

Authors:  Stephen G Henry; Danielle Czarnecki; Valerie C Kahn; Wen-Ying Sylvia Chou; Angela Fagerlin; Peter A Ubel; David R Rovner; Stewart C Alexander; Sara J Knight; Margaret Holmes-Rovner
Journal:  Health Expect       Date:  2013-12-22       Impact factor: 3.377

7.  'It's not like you just had a heart attack': decision-making about active surveillance by men with localized prostate cancer.

Authors:  Robert J Volk; Stephanie L McFall; Scott B Cantor; Theresa L Byrd; Yen-Chi L Le; Deborah A Kuban; Patricia Dolan Mullen
Journal:  Psychooncology       Date:  2013-11-14       Impact factor: 3.894

8.  Effectiveness of Decision Aid in Men with Localized Prostate Cancer: a Multicenter Randomized Controlled Trial at Tertiary Referral Hospitals in an Asia Pacific Country.

Authors:  N B Jalil; P Y Lee; M Z Nor Afiah; K L Abdullah; F N S Mohd Azizi; N N S Abdul Rassip; T A Ong; C J Ng; Y K Lee; A T Cheong; A H Razack; M Saad; A Alip; R Malek; M Sundram; S Omar; J R Sathiyananthan; P Kumar
Journal:  J Cancer Educ       Date:  2022-02       Impact factor: 2.037

9.  Evolution of a CDC Public Health Research Agenda for Low-Risk Prostate Cancer.

Authors:  Ingrid J Hall; Judith Lee Smith
Journal:  Am J Prev Med       Date:  2015-12       Impact factor: 5.043

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.